Skip to main content
. 2022 Jul 11;88(12):5238–5256. doi: 10.1111/bcp.15428

TABLE 2.

Subject demographics (Part B)

Cohort 1 Cohort 2 All placebo Overall
PART B 20 mg 40 mg (part B) (part B)
(n = 8) (n = 8) (n = 4) (n = 20)
Age (y)
Mean 28 23.4 27.3 26
(SD) 6.93 5.13 5.91 6.15
Minimum 19 19 19 19
Median 29.5 21 29 25
Maximum 35 34 32 35
BMI (kg/m 2 )
Mean 24.83 24.86 25.3 24.94
(SD) 2.636 3.158 3.542 2.872
Minimum 19.5 19.5 21.4 19.5
Median 24.7 25.2 25.3 24.95
Maximum 27.9 29.1 29.2 29.2
Height (cm)
Mean 175.08 183.99 175.23 178.67
(SD) 7.186 4.634 3.706 6.997
Minimum 165.5 175 171 165.5
Median 175.05 185 174.95 179.2
Maximum 185 189.2 180 189.2
Weight (kg)
Mean 76.08 84.21 77.93 79.7
(SD) 9.022 11.588 12.883 10.974
Minimum 57.7 62.9 62.5 57.7
Median 76.25 85.65 80.15 80.45
Maximum 89.3 102.4 88.9 102.4
Ethnicity, n (%)
Hispanic or Latino: 0 0 0 0
Not Hispanic or Latino: 8 (100.0) 8 (100.0) 4 (100.0) 20 (100.0)
Race, n (%)
Black or African American 0 0 0 0
American Indian or Alaskan native 0 0 0 0
Asian 0 0 0 0
Native Hawaiian or other Pacific islander 0 0 0 0
White 8 (100.0) 8 (100.0) 4 (100.0) 20 (100.0)
Other 0 0 0 0

Abbreviation: SD, standard deviation.